Health and Community Sciences: Recent submissions
Now showing items 1-5 of 280
-
Support for hospital doctors’ workplace well-being in England: the Care Under Pressure 3 realist evaluation
(BMJ Publishing, 11 April 2025)INTRODUCTION: The vital role of medical workforce well-being for improving patient experience and population health while assuring safety and reducing costs is recognised internationally. Yet the persistence of poor ... -
Early Laser for Burn Scars (ELABS) - Randomised controlled trial of pulsed dye laser treatment and standard care versus standard care alone for the treatment of hypertrophic burn scars
(Elsevier, 17 April 2025)Background Hypertrophic burn scarring (HBS) is described as “the greatest unmet challenge after burn injury”. This ELABS trial hypothesised that early pulsed dye laser (PDL) treatment of HBS improves both scar quality and ... -
Patterns of intra-cluster correlation coefficients in school-based cluster randomised controlled trials of interventions for improving social-emotional functioning outcomes in pupils: a secondary data analysis of five UK-based studies
(BMC, 2025)Background: The cluster randomised trial (CRT) design is increasingly used to evaluate the impact of schoolbased interventions for improving social-emotional functioning outcomes in pupils. Good knowledge is required on ... -
Feasibility study of the implementation of health promoting processes in a secondary school and ways to capture its impact on adolescent lifestyle choices
(Elsevier, 15 February 2025)Objectives: Schools are environments that influence adolescent health choices; understanding schools as complex adaptive systems, we have developed a series of processes that are adaptive to the school context, to support ... -
Widening patient engagement for rare disease drug trials: The perspectives of patients with Idiopathic Pulmonary Fibrosis on participating in clinical drug trials and drug trial design
(Wiley, 15 April 2025)Background: Research about patient engagement for people with rare diseases has identified how the experiences of some members of the public are overlooked in relation to clinical trial design and trial participation. As ...